Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bristow

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Cell Reports|January 10, 2019
Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative PhosphorylationYuting Sun, Madhavi Bandi, Timothy Lofton, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
Characterization of HPV and host genome interactions in primary head and neck cancersMichael Parfenov, Chandra Sekhar Pedamallu, Nils Gehlenborg, et al.
Cell Metabolism|April 10, 2018
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell TherapyTina Cascone, Jodi A McKenzie, Rina M Mbofung, et al.
Nature Communications|July 31, 2021
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinomaVirginia Giuliani, Meredith A Miller, Chiu-Yi Liu, et al.
Cancer Cell|May 13, 2015
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndromeSimona Colla, Derrick Sek Tong Ong, Yamini Ogoti, et al.
Nature Cancer|June 26, 2023
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancerLuigi Perelli, Federica Carbone, Li Zhang, et al.
Cancer Cell|August 16, 2017
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaA Gordon Robertson, Juliann Shih, Christina Yau, et al.
Cancer Cell|May 23, 2017
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway AlterationsYiqun Zhang, Patrick Kwok-Shing Ng, Melanie Kucherlapati, et al.
Journal of Medicinal Chemistry|October 29, 2020
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical PropertiesMichael J Soth, Kang Le, Maria Emilia Di Francesco, et al.
Cancer Research|September 15, 2020
Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward OsimertinibYuting Sun, Brooke A Meyers, Barbara Czako, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Cell Reports|January 10, 2019
Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative PhosphorylationYuting Sun, Madhavi Bandi, Timothy Lofton, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
Characterization of HPV and host genome interactions in primary head and neck cancersMichael Parfenov, Chandra Sekhar Pedamallu, Nils Gehlenborg, et al.
Cell Metabolism|April 10, 2018
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell TherapyTina Cascone, Jodi A McKenzie, Rina M Mbofung, et al.
Nature Communications|July 31, 2021
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinomaVirginia Giuliani, Meredith A Miller, Chiu-Yi Liu, et al.
Cancer Cell|May 13, 2015
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndromeSimona Colla, Derrick Sek Tong Ong, Yamini Ogoti, et al.
Nature Cancer|June 26, 2023
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancerLuigi Perelli, Federica Carbone, Li Zhang, et al.
Cancer Cell|August 16, 2017
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaA Gordon Robertson, Juliann Shih, Christina Yau, et al.
Cancer Cell|May 23, 2017
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway AlterationsYiqun Zhang, Patrick Kwok-Shing Ng, Melanie Kucherlapati, et al.
Journal of Medicinal Chemistry|October 29, 2020
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical PropertiesMichael J Soth, Kang Le, Maria Emilia Di Francesco, et al.
Cancer Research|September 15, 2020
Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward OsimertinibYuting Sun, Brooke A Meyers, Barbara Czako, et al.
Pageof 12